Similar articles

• Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis.

  Sakamoto T, Ogawa H, Yasue H, Oda Y, Kitajima S, Tsumoto K, Mizokami H. Sakamoto T, et al. Circulation. 1994 Jul;90(1):427-32. doi: 10.1161/01.cir.90.1.427. Circulation. 1994. PMID: 8026029
• Adjunctive therapy in thrombolysis for acute myocardial infarction.

  Bleich SD, Rolston WA, Tilton GD, Mailander L. Bleich SD, et al. Z Kardiol. 1993;82 Suppl 2:179-82. Z Kardiol. 1993. PMID: 8328199 Review.
• Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.

  Fuster V, Stein B, Badimon L, Chesebro JH. Fuster V, et al. J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):78A-84A. doi: 10.1016/0735-1097(88)92644-7. J Am Coll Cardiol. 1988. PMID: 3057038 Review.
• Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis.

  Veen G, de Boer MJ, Zijlstra F, Verheugt FW. Veen G, et al. Am J Cardiol. 1999 Oct 1;84(7):763-7. doi: 10.1016/s0002-9149(99)00434-8. Am J Cardiol. 1999. PMID: 10513770
• [Impact of the effectiveness of myocardial reperfusion after thrombolytic and spontaneous recanalization of infarct related artery on myocardial recovery in the future].

  Kalinauskiene E, Vaicekavicius E. Kalinauskiene E, et al. Medicina (Kaunas). 2002;38(1):25-30. Medicina (Kaunas). 2002. PMID: 12474713 Lithuanian.